Johnson & Johnson coronavirus vaccine’s benefits still outweigh risks, CDC data show
By Jacqueline Howard, CNN The benefits of the Johnson & Johnson Janssen coronavirus vaccine still outweigh potential risks, according to data from the US Centers for Disease Control and Prevention. “Many hospitalizations, ICU admissions and deaths can be prevented through Janssen and mRNA Covid-19 vaccines, far outweighing the risks,” CDC researcher Dr. Hannah Rosenblum told
Continue Reading